We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic User-Fee Negotiations to Continue Until End of July
Generic User-Fee Negotiations to Continue Until End of July
July 8, 2011
Despite “general agreement” on many issues, further discussion is still needed on generic-drug user fees, so the FDA and industry have extended their negotiations until the end of July, according to minutes from a closed-door negotiation meeting held June 9 and made public June 28.